Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -974.68% is 11% above its 4-year average of -1093.16%, near the high end of its 4-year range (-5802.84%–18.49%).
69.20% above its 12-month average of -3164.29%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5802.84%.
NET PROFIT MARGIN
-974.68%
NET PROFIT MARGIN AVG TTM
-3164.29%
NET PROFIT MARGIN AVG 3Y
-1408.74%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+69.20%
CURRENT VS 3Y AVG
+30.81%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 629 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
iTonic Holdings Ltd.
Market Cap
$37.15M
Net Profit Margin
-974.68%
TTM Avg
-3164.29%
3Y Avg
-1408.74%
5Y Avg
N/A
Market Cap
$37.23M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-322.60%
Market Cap
$36.48M
Net Profit Margin
-65.29%
TTM Avg
-26.68%
3Y Avg
-11.11%
5Y Avg
-8.71%
Market Cap
$36.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
Market Cap
$38.52M
Net Profit Margin
-11.86%
TTM Avg
-39.34%
3Y Avg
-22.53%
5Y Avg
-16.34%
Market Cap
$38.71M
Net Profit Margin
0.00%
TTM Avg
-27258.72%
3Y Avg
-52085.61%
5Y Avg
-35139.97%
Market Cap
$35.53M
Net Profit Margin
-12.24%
TTM Avg
-6.29%
3Y Avg
-4.54%
5Y Avg
-3.49%
Market Cap
$35.06M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$39.63M
Net Profit Margin
8.38%
TTM Avg
3.43%
3Y Avg
-19.55%
5Y Avg
-29.01%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iTonic Holdings Ltd. (ITOC) | $37.15M | -974.68% | -3164.29% | -1408.74% | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $37.23M | 0.00% | 0.00% | 0.00% | -322.60% |
| DocGo Inc. (DCGO)vs › | $36.48M | -65.29% | -26.68% | -11.11% | -8.71% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.13M | 0.00% | 0.00% | 0.00% | -479.12% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | -11.86% | -39.34% | -22.53% | -16.34% |
| Incannex Healthcare Limited (IXHL)vs › | $38.71M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
| Accuray Incorporated (ARAY)vs › | $35.53M | -12.24% | -6.29% | -4.54% | -3.49% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nephros, Inc. (NEPH)vs › | $39.63M | 8.38% | 3.43% | -19.55% | -29.01% |
| Elutia Inc (ELUT)vs › | $34.48M | 426.93% | 106.45% | -19.31% | -30.13% |
Operating Margin
-991.7%
Net Profit Margin
-974.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -5802.84% |
| 2025-12-31 | -671.84% |
| 2025-06-30 | -3018.20% |
| 2024-12-31 | -157.95% |
| 2024-06-30 | -135.46% |
| 2023-12-31 | -43.56% |
| 2023-06-30 | -31.34% |
| 2022-12-31 | 4.24% |
| 2022-06-30 | 18.49% |
